SCHEMBL14370170

SCHEMBL14370170

CN1CCN(c2cccc3c2O[C@@H](C(=O)Nc2ccc(N4CCOCC4)cc2)CC3)CC1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 2/20 0.73
▸ KCNH2 Q12809 1/20 0.73
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.47
▸ RAD52 P43351 1/20 0.46
▸ MAPT P10636 4/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NFKB1 P19838 4/20 0.44
▸ NFKB2 Q00653 4/20 0.44
▸ RELA Q04206 4/20 0.44
▸ GAA P10253 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5354642 1.00 HTR1B (0.73) HTR1BKCNH2NPC1RAB9AL3MBTL1
SCHEMBL14263999 1.00 HTR1B (0.73) HTR1BKCNH2NPC1RAB9AL3MBTL1
SCHEMBL22411172 0.87 HTR1B (0.57) HTR1BKCNH2L3MBTL1ALDH1A1MAPT
SCHEMBL5308358 0.87 HTR1B (0.79) HTR1BKCNH2NPC1RAB9AALDH1A1
SCHEMBL5308451 0.86 HTR1B (0.78) HTR1BKCNH2NPC1RAB9AL3MBTL1
SCHEMBL4247675 0.84 HTR1B (1.00) HTR1BKCNH2NPC1RAB9AALDH1A1
SCHEMBL4247047 0.84 HTR1B (1.00) HTR1BKCNH2NPC1RAB9AALDH1A1
SCHEMBL14264000 0.84 HTR1B (0.57) HTR1BKCNH2NPC1RAB9AL3MBTL1
SCHEMBL14370221 0.84 HTR1B (0.57) HTR1BKCNH2NPC1RAB9AL3MBTL1
SCHEMBL22410996 0.84 HTR1B (0.53) HTR1BKCNH2NPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285662-B2 Therapeutic heterocyclic compounds ASTRAZENECA AB (SE) 2007-10-23 — — US disclosed
US-7285662-B2 Therapeutic heterocyclic compounds ASTRAZENECA AB (SE) 2007-10-23 — — US disclosed
Send feedback